Rockefeller Capital Management’s Applied Therapeutics APLT Stock Holding History

Rockefeller Capital Management’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-241,897	Closed	-$24.2K	–	4694
2025 Q4	$24.2K	Sell	241,897 -150,000	-38%	-$95.3K	﹤0.01%	3427
2025 Q3	$237K	Buy	+391,897	New	+$185K	﹤0.01%	2142
2024 Q4	–	Sell	-150,000	Closed	-$1.27M	–	1657
2024 Q3	$1.27M	Hold	150,000	–	–	﹤0.01%	1145
2024 Q2	$701K	Hold	150,000	–	–	﹤0.01%	1340
2024 Q1	$1.02M	Buy	+150,000	New	+$673K	﹤0.01%	1253

Rockefeller Capital Management's APLT Position: Q1 2026 in Review

Rockefeller Capital Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 241,897 shares — an estimated $24.2K sold.

Rockefeller Capital Management first reported a position in APLT in Q1 2024 and held it in 5 quarters. The position peaked at $1.27M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Rockefeller Capital Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Rockefeller Capital Management sold 241,897 Applied Therapeutics shares in Q1 2026, an estimated $24.2K.
Rockefeller Capital Management first reported a position in Applied Therapeutics in Q1 2024 and held it in 5 quarters.
Rockefeller Capital Management's Applied Therapeutics position peaked at $1.27M in Q3 2024.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.